- You are here:
-
Home
- News
News
- Details
- Category: POZ.com
The placebo-controlled trial compared injections of cabotegravir given every eight weeks versus daily Truvada as PrEP.
- Details
- Category: POZ.com
Disruptions in access to antiretroviral treatment due to the COVID-19 pandemic could lead to a major setback in combating HIV.
- Details
- Category: POZ.com
Plus: Their stigma-busting initiative gets a shout-out from POZ’s Best Celebrity Advocate 2019.
- Details
- Category: POZ.com
Antiretrovirals likely drive up rates, both directly and by helping people live long enough to develop high blood pressure.
- Details
- Category: POZ.com
The federal government can require foreign affiliates of U.S. companies to denounce sex work in order to secure HIV funding.
- Details
- Category: POZ.com
The global supply of tenofovir and six other important generic drugs must be ensured, warns a UNAIDS analysis.
- Details
- Category: POZ.com
The agency has also lowered the weight threshold for film-coated tablets of the integrase inhibitor Tivicay (dolutegravir).
- Details
- Category: POZ.com
Having an undetectable viral load did not change the risk, which nevertheless was not as severe as the risk tied to diabetes.
- Details
- Category: POZ.com
The country’s National Health Service was to provide the HIV prevention drug for free starting this spring.
Subcategories
Fundraisers Article Count: 2
Health Article Count: 4
HIV / AIDS Article Count: 4
Partners Article Count: 348
POZ.com Article Count: 347
POZ Stories Article Count: 43
Page 10 of 30
- You are here:
-
Home
- News